Patents by Inventor A Rim Kim

A Rim Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240159828
    Abstract: A test mode control circuit includes an encryption circuit and a test mode generating circuit. The encryption circuit encrypts, based on an encryption code, an access code set to generate an encrypted access code set. The test mode generating circuit generates a test mode signal based on the encrypted access code set.
    Type: Application
    Filed: February 27, 2023
    Publication date: May 16, 2024
    Inventors: Jin Suk OH, Young Jae AN, Bok Rim KO, Jae Heung KIM, Min Wook OH
  • Patent number: 11980649
    Abstract: The Agastache rugosa and licorice complex mixture of the present invention has the synergy effects for the efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD11b+ cell ratio reduction, and suppressing sputum production through inhibition of MUC5AC activity and therefore it can be widely utilized as a composition for the prevention or treatment of respiratory diseases.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: May 14, 2024
    Assignees: Cosmax NBT, Inc., Cosmax NS. Inc.
    Inventors: Jeong Ho Geum, Hye Rim Kim, Jin Hak Kim, Su Young Choi
  • Publication number: 20240155225
    Abstract: A lens module assembly optimization method includes: in preparing a lens module including assembled N lenses respectively formed in cavities: receiving characteristic information of at least N lenses respectively formed in N cavity groups each including a respective plurality of cavities; and processing information for selecting N cavities from the N cavity groups, based on the characteristic information. A past cavity selection result, a fitness function configured based on data of the assembled N lenses or data of the prepared lens module according to the past cavity selection result, and a genetic algorithm are received or stored.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Applicants: SAMSUNG ELECTRO-MECHANICS CO., LTD., KYONGGI UNIVERSITY INDUSTRY & ACADEMIA COOPERATION FOUNDATION
    Inventors: Hye Geun MIN, Ye Rim CHOI, Yeon Bin SON, Sung Hoon KIM, Eun Young CHOI
  • Publication number: 20240148871
    Abstract: The present invention relates to a hydrogel composition comprising a chloroplast, a chloroplast transit peptide, alginate, and a pancreatic cell, and can supply oxygen to a cell or a tissue and control carbon dioxide and exhibits excellent preventive or therapeutic effects on diseases such as diabetes, etc., and thus may be utilized in the tissue engineering field such as organ transplant.
    Type: Application
    Filed: March 18, 2022
    Publication date: May 9, 2024
    Applicant: IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG
    Inventors: Dong Yun LEE, Seon Mi JANG, Chae Rim YOO, Ji Yun Kim
  • Patent number: 11973111
    Abstract: A semiconductor device is provided. The semiconductor device includes a substrate, an active pattern extending in a first horizontal direction on the substrate, a gate electrode extending in a second horizontal direction different from the first horizontal direction on the active pattern, a source/drain region on at least one side of the gate electrode, a source/drain contact extending into the source/drain region and including a filling layer and a barrier layer along a sidewall of the filling layer, and a silicide layer between the source/drain region and the filling layer, the silicide layer including a first sidewall in contact with the filling layer and a second sidewall in contact with the source/drain region, wherein the barrier layer is not between the filling layer and the source/drain region.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: April 30, 2024
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Mun Hyeon Kim, Kern Rim, Dae Won Ha
  • Publication number: 20240133888
    Abstract: The present disclosure relates to a nanostructure for detecting viruses including an amphipathic polymer, and a diagnostic platform using the same, wherein the nanostructure is capable of specifically detecting viruses through silica-based nanoparticles with excellent stability and high dispersion and a biocompatible amphipathic polymer, such that it is possible to develop a diagnostic platform with high sensitivity through binding and agglomeration of the nanostructure and viruses and enable rapid and accurate diagnosis of a target virus.
    Type: Application
    Filed: October 17, 2023
    Publication date: April 25, 2024
    Applicant: KNU-INDUSTRY COOPERATION FOUNDATION
    Inventors: HYUN OUK KIM, JAE WON CHOI, SO JIN SHIN, YU RIM AHN, HEE WON AN, MIN SE KIM, HAK SEON KIM
  • Publication number: 20240128930
    Abstract: The present disclosure relates to an offset elimination operation of an internal operational amplifier of a data driving circuit and relates to a technique that applies different offset elimination methods for each position of an operational amplifier.
    Type: Application
    Filed: October 13, 2023
    Publication date: April 18, 2024
    Applicant: LX SEMICON CO., LTD.
    Inventors: Yong Sung AHN, Ji Won KIM, Hyo Joong KIM, Kyung Min SHIN, Kyu Tae LEE, Ha Rim CHOI
  • Publication number: 20240116366
    Abstract: In a control method of a motor drive system, when a first motor corresponding to a first drive wheel is being driven in a second drive mode among a first drive mode in which the first motor is driven by a first inverter of the motor drive system and connected to a first end of each of coils of the first motor and the second drive mode in which the first motor is driven by the first inverter and a second inverter connected to a second end of each of the coils and configured to selectively operate, whether or not the second inverter malfunctions is determined. When the second inverter malfunctions, a drive mode is changed so that the first motor is driven in the first drive mode. An output limit of the first motor in the first drive mode is relaxed.
    Type: Application
    Filed: May 8, 2023
    Publication date: April 11, 2024
    Applicants: Hyundai Motor Company, Kia Corporation
    Inventors: Seung Hyeon BIN, Byung Oh Tak, Seong Min Kim, Ho Rim Choi
  • Publication number: 20240116372
    Abstract: An electrified vehicle includes a motor including a plurality of windings, a first inverter connected to a first end of each of the plurality of windings and configured to drive the motor, a second inverter connected to a second end of each of the plurality of windings and configured to drive the motor in a second driving mode of a first driving mode and the second driving mode, a first controller configured to determine one of first and second output limit lines as an output limit line of the first driving mode, depending on whether a preset condition is satisfied, and a second controller configured to bidirectionally switch the first driving mode and the second driving mode within an operating point range according to the output limit line of the first driving mode in accordance with a value of a torque command for the motor and counter magnetic flux of the motor.
    Type: Application
    Filed: March 2, 2023
    Publication date: April 11, 2024
    Applicants: Hyundai Motor Company, Kia Corporation
    Inventors: Seung Hyeon BIN, Byung Oh TAK, Seong Min KIM, Ho Rim CHOI
  • Patent number: 11951130
    Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: April 9, 2024
    Assignee: Eutilex Co., Ltd.
    Inventors: Byoung S. Kwon, Young Ho Kim, Kwang Hee Kim, Ji Won Chung, Young Gyoon Chang, Bo Rim Yi, Jung Yun Lee, Seung Hyun Lee, Sun Woo Im, Jin Kyung Choi, Hyun Tae Son, Eun Hye Yoo
  • Publication number: 20240106362
    Abstract: A motor driving apparatus includes a motor having a plurality of windings, a first inverter which is connected to a first end of each of the plurality of windings and drives the motor, a second inverter which is connected to a second end of each of the plurality of windings and selectively drives the motor according to a motor drive mode, and a controller which generates a current command for the motor according to a torque command and a voltage utilization rate control value, determines whether to perform linearization control for the current command based on a present counter magnetic flux of the motor and a switching reference counter magnetic flux for the motor drive mode, and adjusts the voltage utilization rate control value such that a value of the current command is linearized in a section in which the linearization control is performed.
    Type: Application
    Filed: April 14, 2023
    Publication date: March 28, 2024
    Applicants: Hyundai Motor Company, Kia Corporation
    Inventors: Ho Rim CHOI, Seong Min KIM, Seon Mi LEE, Tae Il YOO, Seung Hyeon BIN
  • Patent number: 11938827
    Abstract: The present disclosure relates to a system for controlling a motor of a vehicle for increasing control accuracy of the motor for driving the vehicle, and an object of the present disclosure is to provide a system for controlling a motor of a vehicle, which may accurately perform a motor control even when a battery voltage (i.e., motor voltage) applied to the motor upon the driving control of the motor is changed.
    Type: Grant
    Filed: July 13, 2022
    Date of Patent: March 26, 2024
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Ho Sun Jang, Han Hee Park, Seong Min Kim, Ho Rim Choi, Seon Mi Lee, Tae Il Yoo, Seung Hyeon Bin
  • Publication number: 20240097535
    Abstract: An electric compressor capable of reducing a size and lightening weight of a package of an inverter unit, as a common mode choke (CM choke) is disposed radially outside of a circuit board of the inverter unit, and a high voltage connector, a CM choke, and a low voltage connector are integrated into a support body.
    Type: Application
    Filed: September 6, 2022
    Publication date: March 21, 2024
    Inventors: Hyun Woo Lee, Min Gyu Kim, Sang Woo Bae, Hye Rim An, Sung Taeg Oh, Je Su Yun
  • Publication number: 20240081663
    Abstract: An apparatus for non-invasively estimating bio-information and a method of determining whether a bio-signal is normal by the apparatus for estimating bio-information are provided. The apparatus for estimating bio-information according to an embodiment of the disclosure includes: a photoplethysmogram (PPG) sensor configured to measure a PPG signal from an object; and a processor configured to extract a plurality of pairs of local maximum points and local minimum points from a second derivative signal of the PPG signal, to select at least one reference pair from among the extracted plurality of pairs, and to determine whether the PPG signal is normal based on the selected at least one reference pair.
    Type: Application
    Filed: March 7, 2023
    Publication date: March 14, 2024
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Chang Soon PARK, Ui Kum Kwon, Young Soo Kim, Hye Rim Lim
  • Publication number: 20240085786
    Abstract: The present invention relates to a naphthalimide sulfonate derivative, and a photoacid generator and a photoresist composition each comprising same and, more specifically, to a naphthalimide sulfonate derivative compound, and a photoacid generator and a photoresist composition each comprising same, wherein the compound has excellent absorbance for light of i-line (365 nm) wavelength, is greatly easy to prepare into a polymerizable composition due to very high solubility in an organic solvent, has good thermal stability, and shows a favorable acid generation rate.
    Type: Application
    Filed: December 28, 2021
    Publication date: March 14, 2024
    Applicant: SAMYANG CORPORATION
    Inventors: Chun Rim OH, Dae Hyuk CHOI, Yu Na CHOI, Deuk Rak LEE, Ji Eun CHOI, Ki Tae KANG, Min Jung KIM, Won Jung LEE, Chi Wan LEE
  • Publication number: 20240074708
    Abstract: It is disclosed a blood glucose prediction system and method using saliva-based artificial intelligence deep learning technique.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 7, 2024
    Applicant: DONG WOON ANATECH CO., LTD.
    Inventors: In Su Jang, Min Su Kwon, Hee Jung Kwon, Sung Hwan Chung, Eun Hye Im, Ji Won Kye, Eun Hyun Shim, Hee Jin Kim, Mi Rim Kim, Hyun Seok Cho, Dong Cheol Kim
  • Publication number: 20240075318
    Abstract: The present disclosure relates to a method for carrying out dose delivery quality assurance for high-precision radiation treatment, in which parameters affecting a pass rate of dose delivery quality assurance can be derived through regression analysis, which is a known statistical analysis method, and a pass rate prediction model capable of predicting each parameter and the pass rate of dose delivery quality assurance can be derived, and accordingly, it can be predicted in advance whether dose delivery quality assurance will be passed according to the parameters through the above prediction model, without repeatedly carrying out dose delivery quality assurance according to a patient's treatment plan, and as a result, the efficiency of dose delivery quality assurance can be enhanced, and the time or capacity required for such quality assurance is reduced, such that radiation treatment for an actual patient can be quickly and precisely carried out.
    Type: Application
    Filed: December 22, 2021
    Publication date: March 7, 2024
    Inventors: Young Nam KANG, Ji Na KIM, Hong Seok JANG, Byung Ock CHOI, Yun Ji SEOL, Tae Geon OH, Na Young AN, Jae Hyeon LEE, Kyu Min HAN, Ye Rim SHIN
  • Patent number: 11922670
    Abstract: A system comprises a LiDAR sensor and a processor coupled to the LiDAR. The processor is configured to derive a regression line, and generate the outline of the static object by connecting the classified valid points except for the classified removal points. Wherein the processor is further configured to calculate an angle defined by one segment and another segment adjacent to the segment, select an i-lth point, which is a start point of a segment including an ith point, as a start point, when an angle between segments at both sides with respect to the ith point is greater than the reference angle, and select a jth point as an end point, when an angle between segments at both sides with respect to the jth point is less than or equal to the reference angle and when there is the start point before the jth point.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: March 5, 2024
    Assignees: HYUNDAI MOTOR COMPANY, KIA CORPORATION
    Inventors: Mi Rim Noh, Byoung Kwang Kim
  • Publication number: 20240069028
    Abstract: Provided are biomarkers for predicting the prognosis of cervical cancer. In the case of using the biomarkers of the present disclosure, it is possible to select patients into a high-risk group, an intermediate-risk group, or a low-risk group, and thus, it is possible to provide tailored treatment for each patient according to prognosis prediction.
    Type: Application
    Filed: August 23, 2023
    Publication date: February 29, 2024
    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Hanbyoul Cho, Jae-Hoon Kim, Joon-Yong Chung, Hee Yun, Gwan Hee Han, Hye Rim Kim
  • Publication number: 20240067668
    Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.
    Type: Application
    Filed: December 29, 2021
    Publication date: February 29, 2024
    Inventors: Yi Kyung Ko, Ah Reum Han, Jin Hee Park, Yeong Deok Lee, Hye Rim Im, Kyun Eun Kim, Dong Keun Hwang, Su Been Nam, Myung Hoe Heo, Se Rin Cho, Eun Hwa Ko, Sung Hwan Kim, Hwan Geun Choi